Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

29 Oct 2020 07:00

RNS Number : 5345D
Biome Technologies PLC
29 October 2020
 

29 October 2020

Biome Technologies plc

("Biome", the "Group" or the "Company")

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides a trading update for the nine months ended 30 September 2020.

 

Bioplastics Division

 

Revenues in the Bioplastics division in Q3 at £1.6m were 48% ahead of the previous quarter (Q2 2020: £1.1m) and 131% ahead of the prior year comparative (Q3 2019: £0.7m).

 

The division's revenues in the first nine months of the financial year stood at £3.8m, 93% ahead of the equivalent period last year (2019: £2.0m).

 

Revenues in Q3 reflected strong underlying demand for products that have been commercialised for some time (e.g. outer packaging and non-woven filter mesh applications for the US coffee market), coupled with growing revenues in rigid materials used in coffee pods. The Board expects revenues in Q4 to be below the Q3 quarterly level but in line with its expectations for this financial year.

 

The Bioplastics division is working with an expanding list of potential new customers, particularly in the US. Developmental work related to this continues with some vigour, despite the impact of Covid-19. In particular, the implementation of a filtration mesh project with a second US end-customer has moved forward assuredly and initial revenues are expected later this quarter.

 

During Q3, the activities of the Bioplastics division were recognised when Biome received the London Stock Exchange's Green Economy Mark. The Green Economy Mark, launched in 2019, recognises listed companies and funds which derive 50% or more of their revenues from environmental solutions.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q3 were £0.2m (Q3 2019: £0.6m), resulting in revenues in the first nine months of the financial year of £0.6m (2019: £2.8m).

 

The fibre optic cable market, normally a major driver of the business, remains impacted by both over-capacity and COVID-19 disruption. The division continues to make a concerted effort to increase its geographic footprint and range of applications and already benefits from recurring revenue from power generation, medical and general industrial markets.

The business has continued to win small projects in the UK induction heating and welding market, but overall demand remains subdued.

 

 

Group Performance

 

Total Group revenues in Q3 were £1.8m (2019: £1.3m) taking Group revenues for the nine months to 30 September 2020 to £4.3m (2019: £4.7m). It is to be noted that all revenue figures in this statement exclude grant income (£38,000 in the third quarter of this year and £124,000 for the nine months).

 

Costs and capital expenditure continue to be managed tightly and as the Government furlough scheme ends in October, activity levels are such that staff are returning to normal duties.

 

The Group's cash position as at 30 September 2020 was £0.9m (30 June 2020: £1.1m) and the Group had no debt.

 

 

In September 2020, the Group announced that it had raised £1.1m (£1.0m net of costs), via a fundraising made up of three tranches, to support and accelerate the Bioplastics division's growth. Shareholder approval was obtained on 12 October 2020 and the net proceeds from the first and second tranches have now been received which enhances the Group's cash position from that at the end of Q3.

 

Group Outlook

 

The funds from the recent fundraise will support a vigorous approach to growing the Group's bioplastics business. It is against the above that the Board expects the full year results to be in line with current market expectations.

 

Ends-

 

For further information please contact: Biome Technologies plc

Paul Mines, Chief Executive Officer

Donna Simpson-Strange, Company Secretary

info@biometechnologiesplc.co.uk

Tel: +44 (0) 2380 867 100

www.biometechnologiesplc.com

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Equity Sales)

Tel: +44 (0) 20 3328 5656

www.allenbycapital.com

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where value-added pricing can be justified and which are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKFBNCBDDKKB
Date   Source Headline
14th Jun 201012:31 pmRNSResult of Meeting
14th Jun 20107:00 amRNSResult of the Firm Placing, Placing and Open Offer
27th May 20104:15 pmRNSPublication of Prospectus
27th May 20107:00 amRNSFirm Placing and Placing and Open Offer
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
21st May 20104:40 pmRNSSecond Price Monitoring Extn
21st May 20104:35 pmRNSPrice Monitoring Extension
30th Apr 20104:40 pmRNSSecond Price Monitoring Extn
30th Apr 20104:35 pmRNSPrice Monitoring Extension
30th Apr 201010:36 amRNSAnnual Report and Accounts
29th Apr 20107:01 amRNSInterim Management Statement
29th Apr 20107:00 amRNSPreliminary Results
19th Apr 20107:00 amRNSUpdate re Novamont S.p.A infringement claims
16th Apr 20107:00 amRNSAnnual Information Update
17th Feb 20108:00 amRNSBiome Bioplastics new HT bioplastic
25th Jan 201010:30 amRNSStanelco re-brands bioplastics business
9th Dec 20098:00 amRNSOrders for Fibre Optics systems in Asia
3rd Dec 20097:00 amRNSStatement re share price movement
25th Nov 20094:40 pmRNSSecond Price Monitoring Extn
25th Nov 20094:35 pmRNSPrice Monitoring Extension
9th Nov 200910:06 amRNSHolding(s) in Company
6th Nov 20097:00 amRNSInterim Management Statement
21st Oct 20093:17 pmRNSHolding(s) in Company
20th Oct 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20094:45 pmRNSHolding(s) in Company
4th Sep 20094:35 pmRNSPrice Monitoring Extension
3rd Sep 20094:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20097:00 amRNSInterim Results
13th Aug 20094:40 pmRNSSecond Price Monitoring Extn
13th Aug 20094:35 pmRNSPrice Monitoring Extension
7th May 20097:00 amRNSDirectors' Dealing
24th Apr 20091:42 pmRNSResult of Annual General Meeting
24th Apr 20097:00 amRNSInterim Management Statement
7th Apr 20097:00 amRNSAnnual Information Update
2nd Apr 20092:01 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSChange of Adviser
30th Mar 20095:36 pmRNSAnnual Report and Accounts and Notice of AGM
26th Mar 20094:35 pmRNSPrice Monitoring Extension
26th Mar 20097:00 amRNSPreliminary Results
19th Dec 20087:01 amRNSDirectorate Change
19th Dec 20087:00 amRNSDirectorate Change
7th Nov 20087:00 amRNSInterim Management Statement
10th Oct 200811:14 amRNSDirector/PDMR Shareholding
2nd Sep 200812:02 pmRNSHolding(s) in Company
29th Aug 20087:00 amRNSInterim Results
22nd Aug 20081:36 pmRNSHolding(s) in Company
30th Jul 20089:02 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.